Skip to content
Lower risk Drug recall · FDA · Published July 25, 2012

American Health Packaging Recalls Topiramate Tablets Due to Label Error

American Health Packaging recalls 1,170 cartons of Topiramate Tablets 50 mg due to a label mix-up listing them as capsules. Check your lot numbers.

🇺🇸 FDA recall #D-1645-2012DrugAmerican Health Packaging ›
Take action

Contact the company

Recalling firmAmerican Health Packaging2550 John Glenn Ave Ste A · Columbus, OH 43217-1188
✎ GovInfoNow plain-language explainer

American Health Packaging is recalling Topiramate Tablets, 50 mg because the carton label incorrectly lists the product form as "Capsules" instead of "Tablets." This labeling error affects 1,170 cartons distributed nationwide. The recall was initiated on July 25, 2012. Read more at govinfonow.com/recall/48613-american-health-packaging-recalls-topiramate-tablets-50-mg-30-count.

Source Summary by GovInfoNow · govinfonow.com/recall/48613-american-health-packaging-recalls-topiramate-tablets-50-mg-30-count · Updated October 13, 2026 · FDA enforcement record: FDA #D-1645-2012

Cite this page

“American Health Packaging Recalls Topiramate Tablets Due to Label Error.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48613-american-health-packaging-recalls-topiramate-tablets-50-mg-30-count. Based on FDA recall #D-1645-2012 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1645-2012%22&limit=1).

American Health Packaging voluntarily recalled Topiramate Tablets, 50 mg, due to a labeling error listing the product as capsules instead of tablets, the FDA said on July 25, 2012. The recall affects 1,170 cartons distributed nationwide.

How to tell if you have it

  • Brand: American Health Packaging
  • Product: Topiramate Tablets 50 mg
  • Configuration: 30-count (3 x 10) unit-dose blisters per carton
  • NDC: 68084-343-21
  • UPC: 6808434311
  • Lot codes: 113032A, 113032B
  • Expiration date: 04/13
  • Manufacturer: Cadila Healthcare Ltd.
  • Distributor: Zydus Pharmaceuticals USA, Inc.

The hazard

The carton label contains a typographical error that incorrectly lists the product configuration as 30 capsules rather than tablets. The FDA classified this labeling mix-up as a Class III recall.

Context

GovInfoNow's records show American Health Packaging has 41 other recalls on record since July 23, 2012. Recent brand recalls include a Buprenorphine Tablets recall for label mix-up hazard on August 19, 2026, and a Nitrofurantoin Capsules recall for dissolution failure risk on May 3, 2022. Other recent recalls of similar products include an American Regent Levocarnitine Injection recall for missing label hazard (April 16, 2026), a Fagron Tropicamide Eye Drops recall due to incorrect formulation (November 20, 2025), and a Haleon Gas-X Simethicone 125mg Softgels recall due to incomplete labeling (May 11, 2026).

How to tell if you have this one

Check your carton for NDC 68084-343-21 and blister barcode 6808434311. Verify the lot numbers are 113032A or 113032B with an expiration date of 04/13. The package contains 30-count (3 x 10) unit-dose blisters.

  • Brand
    American Health Packaging
  • Product
    Topiramate Tablets, 50 mg, 30-count (3 x 10) unit-dose blisters per carton, Rx only, Mfd by: Cadila Healthcare Ltd
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 11 months after the firm started it.

1. Firm started the recall: Jul 25, 201212. FDA classified it Class III: Aug 14, 201223. Published in FDA’s Enforcement Report: Aug 22, 201234. FDA terminated the recall: Jul 2, 2013420122013
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1645-2012 (July 25, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1645-2012 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA